Sat.Apr 03, 2021 - Fri.Apr 09, 2021

article thumbnail

Human trials for world's first AI-designed immuno-oncology drug

Pharma Times

The drug was discovered through an AI-design platform within just eight months of project initiation

149
149
article thumbnail

Is disability the last bastion of the representation debate?

pharmaphorum

From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Plunging Johnson & Johnson Vaccine Supply Dents State Inoculation Efforts

NY Times

With supplies from Johnson & Johnson set to fall 86 percent, a White House official warned that the vaccine would be scarce until a troubled Baltimore plant gains regulatory approval.

article thumbnail

Which pharmaceutical companies have the most drug patents in Russian Federation?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Russian Federation? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Novartis bags EU, UK licences for MS therapy Kesimpta

Pharma Times

Kesimpta is the first self-administered B-cell therapy for patients with relapsing forms of multiple sclerosis

136
136
article thumbnail

Digital tool will be tested against COVID-19 ‘brain fog’

pharmaphorum

A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.

Hospitals 128

More Trending

article thumbnail

Which pharmaceutical companies have the most drug patents in Lithuania?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Thousands to benefit from five-minute breast cancer treatment

Pharma Times

NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time

130
130
article thumbnail

Gilead scores US approval for breast cancer drug that wowed ESMO

pharmaphorum

Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer. . Trodelvy (sacituzumab govitecan) was granted accelerated approval by the FDA in April last year, and is now indicated for adults with triple-negative breast cancer who have received at least two previous therapies for metastatic disease.

article thumbnail

Dive into advanced data, ethical issues at free online event

Outsourcing Pharma

The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.

83
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Stop paying your staff to make repetitive reports

Drug Patent Watch

How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your staff burdened with manual, repetitive tasks, like data collection, and…. The post Stop paying your staff to make repetitive reports appeared first on DrugPatentWatch - Make Better Decisions.

68
article thumbnail

NICE 'no' for Opdivo/Yervoy lung cancer combo

Pharma Times

The combination is not considered to be a cost-effective use of NHS resources in this setting

123
123
article thumbnail

Provention faces delay in FDA review of diabetes prevention antibody

pharmaphorum

The FDA says it has uncovered “deficiencies” in the marketing application for Provention Bio’s much-anticipated drug teplizumab for the prevention of type 1 diabetes (T1D) that could delay its review. The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lill

article thumbnail

Patient centricity vital to advancing rare-disease treatments: ICON

Outsourcing Pharma

A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.

73
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Which pharmaceutical companies have the most drug patents in Brazil?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Brazil? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

EU nod for new formulation of Biogen's Tysabri

Pharma Times

A subcutaneous formulation will now be available to treat relapsing-remitting multiple sclerosis

123
123
article thumbnail

Genmab could spin out autoimmune disease unit, says CEO

pharmaphorum

Genmab’s CEO Jan van de Winkel has said he would consider spinning out a smaller autoimmune diseases biotech, while ruling out any interest in a merger with big pharma. . In an interview with pharmaphorum, van de Winkel noted that the company’s drugs could be used for diseases outside of cancer, where Copenhagen-based Genmab first made its mark. A drug it originally developed to treat leukaemia has been repurposed by Novartis as a treatment for multiple sclerosis.

88
article thumbnail

CISCRP event to boost public awareness of clinical research

Outsourcing Pharma

The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.

72
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Singapore?

Drug Patent Watch

This chart shows the drugs with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Singapore? appeared first on DrugPatentWatch - Make Better Decisions.

55
article thumbnail

Nationwide launch for pioneering fertility study

Pharma Times

The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births

123
123
article thumbnail

Healx deploys its AI in hunt for Friedreich’s ataxia therapies

pharmaphorum

UK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new therapies for the neurodegenerative disease Friedreich’s ataxia (FA). . Healx has joined forces with Ataxia UK and the US-based Friedreich’s Ataxia Research Alliance (FARA) on the project, and will use its AI-powered drug discovery platform Healnet to try to find already used drugs that could be repurposed as treatments for FA.

81
article thumbnail

Patient-centric approach more important than ever: Deloitte

Outsourcing Pharma

Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.

72
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

New patent expiration for Ferrer Internacional drug XEPI

Drug Patent Watch

Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Ferrer Internacional drug XEPI appeared first on DrugPatentWatch - Make Better Decisions.

53
article thumbnail

Benefits of AZ vaccine outweigh risks, says MHRA

Pharma Times

The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine

Vaccines 115
article thumbnail

Cancer Research UK spinout Achilles raises $175.5m in IPO

pharmaphorum

UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. The new funding will also be used to advance two more T cell programmes for head and neck and kidney cancers into human testing, develop and expand its bioinformatics and manufacturing capabilities, and increase its use of automation, according to an SEC filing.

78
article thumbnail

Dedicated dad hopes to run down cure for a rare disease

Outsourcing Pharma

A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.

61
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New patent expiration for Abraxis Bioscience drug ABRAXANE

Drug Patent Watch

Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA. It is available from one supplier. There are twelve patents…. The post New patent expiration for Abraxis Bioscience drug ABRAXANE appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Artios, Novartis form cancer therapies collaboration

Pharma Times

The deal could be worth as much as $1.

115
115
article thumbnail

FDA green lights Oxehealth vital signs monitoring software

pharmaphorum

UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed. . Oxehealth Vital Signs – which has been approved as a class IIa medical device in Europe since 2018 – operates as part of the company’s Oxevision platform, which consists of an optical sensor installed in a patient’s room and provides continuous remote monitoring.

article thumbnail

IQVIA completes acquisition of Q2 Diagnostics

Outsourcing Pharma

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

58
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.